StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Jyong Biotech's total debt was $15.34M at Dec 31, 2025. For fiscal 2025 it was $15.34M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$15.34M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$15.34M–

More Jyong Biotech figures

See a number that looks wrong?